Kinetics of human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II)

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4487-4491

  Kamal, Mohammad Amjad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Acetylcholinesterase; Cis diamminediaquaplatinum,; Erythrocyte; Inhibition; Kinetics

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; CISPLATIN; CISPLATIN DERIVATIVE; CYCLOPHOSPHAMIDE; METHOTREXATE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME KINETICS; ERYTHROCYTE; HUMAN; HUMAN CELL; HYDROLYSIS; INHIBITION KINETICS; MALE; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; CAMELS; CHOLINESTERASE INHIBITORS; CISPLATIN; ERYTHROCYTES; HUMANS; KINETICS; METHOTREXATE; MODELS, CHEMICAL; RETINA;

EID: 0031418951     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Horacek P, Drobnik, J: Interaction of cis-dichlorodiammineplatinum (II) with DNA. Biochem Biophys Acta 254: 341-347, 1971.
2. Bernges F, Holler E: Ring substituted diaqua (1, 2-diphenyl-ethylenediamine) platinum (II) sulfate reacts with DNA through a dissociable complex. Eur J Biochem 208: 573-579, 1992.
3. 2 (N-Py)Cl]+ binding to fumarase. Drug Metabol Drug Interact 12: 105-115, 1995.
4. Kodera Y, Akiyama S, Isobe K, Kondo K, Ito K, Yamauchi M, Takagi H: Expression of pi- glutathione S-transferase gene (GSTP1) in gastric cancer: lack of correlation with resistance against cis-diamminedichloroplatinum (II). Eur J Cancer 30: 2158-2162, 1994.
5. Sadzuka Y, Shoji T, Takino Y: Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43: 1872-1875, 1992.
6. Al-Jafari AA, Kamal MA, Duhaiman AS: The mode of inhibition of human erythrocyte membrane bound acetylcholinesterase by cisplatin in vitro. J Enz Inhibit 8: 281-289, 1995.
7. 50 with time for the inhibition of human erythrocyte acetylcholinesterase by cisplatin. Cell Pharmacol 3: 45-48, 1996.
8. Kamal MA, Nasim FH, Al-Jafari AA: Investigation of the effect of anti-neoplastic drugs: cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholin-esterase. Biochem Mol Biol Int 39: 293-302, 1996.
9. Strukul G, Michelin RA, Orbell JD, Randaccio L: tert-Butylperoxo complexes of platinum (II): synthetic, spectroscopic, and structural investigation. Oxygenation of 1-Octene by trans species. Inorg Chem 22: 3706-3713, 1983.
10. Eastman A: Interstrand cross-links and sequence specificity in the reaction of cis-dichloro (ethylenediamine) platinum (II) with DNA. Biochemistry 24: 5027-5032, 1985.
11. Reed E, Yopsa SH, Zwelling, Ozols RF, Poirier MC: Quantitation of cis-diamminedichloroplatinum II (cisplatin) DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J Clin Invest 77: 545-550, 1986.
12. Pinto AL, Lippard SJ: Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II). Proc Natl Acad Sci USA 82: 4616-4619, 1985.
13. Ciccarelli RB, Solomon MJ, Varhavsky A, Lippard SJ: In vivo effect of cis- and trans-di-amminedichloroplatinum (II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication. Biochem 24: 7533-7540, 1985.
14. Sorensen K, Gentinetta R, Brodback U: An amphiphile dependent form of human brain caudate nucleus acetylcholinesterase: Purification and properties. J Neurochem 39: 1050-1060, 1982.
15. Bourne Y, Taylor P, Marchot P: Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex. Cell 83: 503-512, 1995.
16. Schaller W, Reisner H, Holler E: Kinetic investigation of the DNA platination reaction: evidence for a transient adduct between deoxyribonucleic acid and cis-platinum (II). Biochemistry 26: 943-950, 1987.
17. Al-Jafari AA, Kamal MA: Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase. Biochem Mol Biol Int 38: 577-586, 1996.
18. Kamal MA, Al-Jafari AA: The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase. Prep Biochem Biotech 26: 105-119, 1996.
19. Ellman GL, Courtney D, Andres V, Featherston RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95, 1961.
20. Fersht A: In: Enzyme Structure and Mechanism. San Francisco, W-H Freeman, 1977, pp 91-92.
21. Lowry O H, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin Phenol reagent. J Biol Chem 193: 265-275, 1953.
22. Al-Jafari AA, Kamal MA: The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase. Cell Biochem Funct 12: 29-35, 1994.
23. Al-Jafari AA, Kamal MA: Effect of tetrahydroaminoacridine on the turnover kinetics of camel (Camelus dromedarius) retina acetylcholinesterase. Biochem Mol Biol Int 39: 917-922, 1996.
24. Leatherbarrow RJ: GraFit. Version 3.0, Erithacus Software Ltd., 1992, Staines, U.K.
25. Segel IH: In: Enzyme kinetics: Behaviour and analysis of rapid equilibrium and steady state enzyme systems. New York, John Wiley and Sons, 1975, pp. 108-185.
26. Goldenberg GJ, Vanstone CL, Bihler I: Transport of nitrogen mustard on the transport carrier for choline in L5178Y Lymphoblasts. Science 172: 1148-1149, 1971.
27. Cohen SG, Chishti SB, Bell DA, Howard SI, Salih E, Cohen JB: General occurence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate. Biochem Biophys Acta 1076: 112-122, 1991.
28. Hallak M, Szinicz L: Effects of some mono-and bisquaternary ammonium compounds on the reactivatability of some-inhibited human acetylcholinesterase in vitro, Biochem Pharmacol 37: 819-825, 1988.
29. Kamal MA, Nasim FH, Al-Jafari AA: In vitro inhibition of human erthrocyte acetylcholinesterase (EC 3.1.1.7) by an antineoplastic drug methotrexate. Mol Cell Biochem 159: 47-53, 1996.
30. Al-Jafari AA, Al-Khwyter F, Kamal MA, Alhomida AS: Kinetics for Camel (Camelus dromedarius) retina acetylcholinesterase inhibition by methotrexate in vitro. Jpn J Pharmacol 72: 49-55, 1996.
31. Al-Jafari AA: The toxicological effect of cyclophosphamide on acetylcholinesterase activity. Toxicol Lett 66: 125-131, 1993.
32. Kamal MA: Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase. Anticancer Res 16: 3725-3730, 1996.
33. Al-Jafari AA, Duhaiman AS, Kamal MA: Inhibition of human acetylcholinesterase by cyclophosphamide. Toxicology 96: 1-6, 1995.
34. Al-Khwyter F, Kamal MA, Al-Jafari AA: The inhibitory effect of cyclophosphamide on camel retina acetylcholinesterase activity. Toxicol Lett 87: 69-76, 1996.